SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on the still-unconfirmed 80th-event trigger in SELLASs Phase 3 REGAL AML trial, which precedes the final analysis; traders debate whether the prolonged wait reflects unusually long survival and potential GPS benefit or uncertainty about the trial. Some speculate results may be timed around ASH, while the lack of a confirmed update has fueled frustration and bearish concern alongside bullish expectations amid a sharp pullback.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention amid a sharp futures rebound after a technology-led selloff, with traders debating whether it signals a sustained recovery or is only a short-covering bounce that could fade. Discussion also centers on Black Monday anniversary fears and upcoming Big Tech earnings, which could test sentiment around AI-related stocks.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broad selloff in AI infrastructure and neocloud stocks, as traders debate whether high financing costs, debt exposure and uncertain returns make the sectors data-center expansion unsustainable; concerns about CoreWeaves credit risks are also weighing on peers. Bulls argue Nebius has a stronger balance sheet, durable AI demand and valuable customer relationships, while bears see further downside and a valuation reset.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp rebound in index futures after a tech-led selloff has fueled discussion around the 1987 Black Monday anniversary and upcoming Big Tech earnings. Traders are split on whether the move signals a recovery or is a low-volume short-covering bounce that could fade.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is under heavy selling pressure amid staggered IPO lockup expirations that make more shares eligible for sale, compounded by weakness across AI and semiconductor stocks. Traders disagree over whether further insider selling, lofty valuation, and customer concentration leave room for more downside or whether the selloff is an opportunity to buy the dip as the company expands its AI-inference business.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

ESMO data on Iovances lifileucel is driving attention, especially mature frontline melanoma results for the lifileucelpembrolizumab combination and preliminary sarcoma activity. Traders largely view the melanoma durability data as encouraging support for the ongoing Phase 3 trial, while debating whether the small sarcoma cohort and its lower response rate versus an earlier cut meaningfully strengthen the case for expansion.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is drawing attention after a sharp rally and reports of heavier trading, prompting speculation about further gains or possible news. Some traders point to Flexas payments-and-collateral model and its connection to ANVL, while skeptics say there is no confirmed new catalyst and warn the move could fade like past pumps.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassians push to a new 52-week high, attributed to enterprise demand and customers migrating to its cloud products, has drawn attention. Traders are split between viewing the move as a breakout and expecting resistance or a pullback after the sharp run.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas move to fresh highs is being linked to its stablecoin-powered payment service and Chinas approval for the company to prepare a domestic card-clearing business. Traders are broadly bullish on the breakout and new payment opportunities, while some caution that the rally looks extended and may pull back.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Escalating Middle East tensions, attacks on oil infrastructure and shipping, and continued strikes on Russian refineries are driving concern about disrupted crude and fuel supplies and supporting energy shares. Traders largely see a bullish catalyst in higher oil prices, though some are wary of volatility, profit-taking, and whether XLE can keep pace with crude.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's What Could Help Park Dental Partners, Inc. (PARK) Maintain Its Recent Price Strength

Park Dental Partners, Inc. (PARK) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Q1 Earnings Estimate for PARK Issued By Northland Securities

Park Dental Partners, Inc. (NASDAQ:PARK - Free Report) - Equities research analysts at Northland Securities decreased their Q1 2026 earnings per share estimates for shares of Park Dental Partners in...

Park Dental Partners Q4 Earnings Call Highlights

Park Dental Partners (NASDAQ:PARK) used its fourth-quarter and full-year 2025 earnings call to highlight a record year for revenue and adjusted EBITDA, discuss its early-December IPO, and outline a...

Park Dental Partners (NASDAQ:PARK) Announces Earnings Results, Beats Expectations By $0.37 EPS

Park Dental Partners (NASDAQ:PARK - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.30 earnings per share for the quarter, beating analysts' consensus...

What is Northland Capmk's Forecast for PARK FY2025 Earnings?

Park Dental Partners, Inc. (NASDAQ:PARK - Free Report) - Northland Capmk issued their FY2025 earnings estimates for shares of Park Dental Partners in a report issued on Monday, January 5th. Northland...

Park Dental Partners (NASDAQ:PARK) Now Covered by Analysts at Northland Securities

Northland Securities started coverage on Park Dental Partners in a report on Monday. They issued an "outperform" rating and a $21.50 target price on the stock...

Park Dental Partners, Inc.'s (NASDAQ:PARK) Quiet Period Set To Expire on January 12th

Park Dental Partners' (NASDAQ:PARK - Get Free Report) quiet period will end on Monday, January 12th. Park Dental Partners had issued 1,535,000 shares in its public offering on December 3rd. The total...

Park Dental Partners, Inc. Announces Closing of Initial Public Offering

Park Dental Partners, Inc. (Park Dental Partners or the Company), today announced the closing of its initial public offering of 1,535,000 shares of its common stock at a price to the public of $13.00...

Park Dental Partners, Inc. engages in the provision of comprehensive business support services including clinical team members, administrative personnel, facilities and equipment. The company was founded by Gregory T. Swenson and Brian Murn in 1972 and is headquartered in Roseville, MN.

Park Dental Partners Inc.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$18.95
Prev Close	$19.21
Open	$19.11
Dividend Yield	0.00%
50-Day Moving Average	$20.69
Beta	0.66
Avg. Volume	41,791.03
PE Ratio	-20.61

52-Week High	$26.79
52-Week Low	$9.53
Market Capitalization	$90.11M
EPS (Annual)	-$0.0843
Price to Book	2.99
Revenue Per Employee	$201,727.72

Feed

News

Sentiment

Fundamentals

Info

PARK Fundamentals